Q2 2022 Holdings
Filed 2022-08-15 | 34 holdings | $34.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $8.6M | 225,000 | 25.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $8.1M | 900,000 | 23.8% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $7.0M | 75,000 | 20.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $4.6M | 110,000 | 13.6% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $3.4M | 325,000 | 10.1% |
| Aadi Bioscience Inc(WHWK) | COM | 00032Q104 | $1.8M | 150,000 | 5.4% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $277.0K | 1,900 | 0.8% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $29.7K | 400,000 | 0.1% |
| Celldex Therapeutics Inc New(CLDX)Call | COM NEW | 15117B202 | $10.8K | 400,000 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $10.7K | 1,000,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $10.2K | 225,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $9.7K | 130,000 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $8.0K | 100,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $7.4K | 110,000 | 0.0% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $7.1K | 325,000 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $6.9K | 600,000 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $6.2K | 35,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $5.7K | 45,000 | 0.0% |
| Merus N V | COM | N5749R100 | $5.7K | 250,000 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $4.8K | 500,000 | 0.0% |
| CTI Biopharma Corp(CTIC1USD) | COM | 12648L601 | $4.8K | 800,000 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $4.7K | 250,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $4.3K | 225,000 | 0.0% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $3.9K | 275,000 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $3.7K | 450,000 | 0.0% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $3.7K | 50,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $3.0K | 165,000 | 0.0% |
| Dice Therapeutics IncCall | COM | 23345J104 | $2.3K | 150,000 | 0.0% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $1.8K | 120,000 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $1.6K | 300,000 | 0.0% |
| 9 Meters Biopharma Inc | COM | 654405109 | $469 | 1,800,000 | 0.0% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $467 | 925,000 | 0.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $466 | 30,000 | 0.0% |